F18-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与动态对比增强磁共振成像作为前交叉韧带重建移植物活性标志物的比较
该病例系列研究纳入27例关节镜下前交叉韧带重建术后患者,在术后平均125±22天和259±38天进行两次随访,比较F18-FDG PET/CT与DCE-MRI评估移植物韧带化并与临床检查相关性分析。结果显示第二次随访时Lysholm评分中位数从78.5显著改善至94.5(P=0.0001),仅胫骨区内SUVmax CL显著降低(P=0.032),PET/CT与MRI参数间无相关性。
要点
- 第二次随访Lysholm评分中位数从78.5显著改善至94.5(P=0.0001)。
- 仅胫骨区内SUVmax CL在第二次随访显著降低(P=0.032)。
- PET/CT与MRI参数间未观察到相关性。
核心结论
- 移植物组织的葡萄糖代谢和血管化可用于评估前交叉韧带移植物的韧带化。
- 第一次随访时移植物有活性且血管化与最终良好至优秀结局相关,无论该阶段Lysholm评分如何。
- 由于PET/CT与MRI参数间未观察到相关性,它们可能评估同一过程的不同领域。
- 第一次随访时胫骨区内较高NE和第二次随访时同一区域较低SUVmax CL与更好结局相关。
研究设计与样本
- 病例系列研究,证据等级4级。
- 共招募30例患者,其中27例(3例女性、24例男性)在关节镜下前交叉韧带重建术后平均125±22天和259±38天完成两次随访评估。
- 27例招募患者中1例因跌倒再损伤,最终26例纳入分析。
- 两次评估均进行前抽屉试验、Lachman试验和Lysholm评分。
- 对F18-FDG PET/CT和MRI图像在股骨区、关节内区和胫骨区三个区域进行定性和定量分析(SUVmax、SUVmax CL、NE)。
主要发现
- 第二次随访时Lysholm评分中位数从78.5(范围62-90)显著改善至94.5(范围84-100)(P=0.0001)。
- PET/CT显示所有移植物有活性,MRI显示所有移植物血管化。
- MRI显示所有移植物连续,除1例移植物在第二次随访时例外。
- 动态MRI在第一次随访时识别所有移植物为单血管供血,第二次随访时10例患者为多血管供血。
- 第二次随访时三个区域的SUVmax、SUVmax CL和NE中位数均降低,仅关节内区SUVmax CL显示显著降低(P=0.032);第二次随访时Lysholm评分优秀患者较良好患者显示显著更高的降低(P=0.005)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: F18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) can be used to assess changes in the metabolism of an anterior cruciate ligament (ACL) graft as it is undergoing "ligamentization." Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is the preferred modality for noninvasive assessment of graft structure and graft vascularity. PURPOSE: To compare the use of F18-FDG PET/CT and DCE-MRI to assess ligamentization within the ACL graft and correlate the results with clinical tests. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Among 30 recruited patients, 27 patients (3 females and 24 males) completed 2 follow-up assessments at a mean of 125 ± 22 days and 259 ± 38 days after arthroscopic ACL reconstruction. At both assessments, anterior drawer test, Lachman test, and Lysholm scoring (LS) were conducted. Images from F18-FDG PET/CT and MRI were analyzed qualitatively and quantitatively (maximum standardized uptake value [SUVmax], SUVmax ratio to the contralateral side [SUVmax CL], normalized enhancement [NE]) in 3 zones: femoral, intra-articular (IA), and tibial. Of the 27 recruited patients, 1 patient had reinjury due to a fall. Therefore, 26 patients were considered for the final analysis. RESULTS: A significant improvement ( P = .0001) was found in median LS, from 78.5 (range, 62-90) to 94.5 (range, 84-100), at the second follow-up. All grafts were found to be viable on PET/CT and vascularized on MRI. All grafts were seen as continuous on MRI, with exception of 1 graft at the second follow-up. Dynamic MRI identified single-vessel supply to all of the grafts at the first follow-up and multiple-vessel supply in 10 patients at the second follow-up. Reduction in the median SUVmax, SUVmax CL, and NE at second follow-up was seen in all 3 zones. Only SUVmax CL in the IA zone showed a significant reduction ( P = .032); patients with excellent LS at the second follow-up showed significantly higher reduction ( P = .005) than patients with good LS. NE in the IA zone was correlated (0.39; P = .048) with LS only at the first follow-up, whereas SUVmax CL (-0.52; P = .006) and SUVmax (-0.49, P = .010) in the IA zone negatively correlated with LS at the second follow-up only. No correlation was observed between PET/CT and MRI parameters. CONCLUSION: Glucose metabolism and vascularity in the graft tissue can be used to assess ligamentization of ACL graft. A viable and vascularized graft at first follow-up is associated with good to excellent final outcome, regardless of LS at this stage. Since no correlation was observed between PET/CT and MRI parameters, they may be assessing different domains of the same process. Higher NE in the IA zone at the first follow-up and lower SUVmax CL in the same region at second follow-up are associated with better outcome.
引用
- Garika SS, Sharma A, Razik A, et al. Comparison of F18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Markers of Graft Viability in Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2018. PMID: 30481047. doi:10.1177/0363546518805092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。